Renee D Gala Jazz Pharmaceuticals PLC (JAZZ) insider trading activity

Renee D Gala is President & COO of Jazz Pharmaceuticals plc. Currently has a direct ownership of 88,895 shares of JAZZ, which is worth approximately $12.3 Million. The most recent transaction as insider was on Mar 05, 2025, when has been sold 5,704 shares (Ordinary Shares) at a price of $138.95 per share, resulting in proceeds of $792,570. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 88.9K

60.19% 3M change

55.7% 12M change

Total Value Held $12.3 Million

RENEE D GALA Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Mar 05 2025	SELL Sale (or disposition) back to the issuer	$792,570 $138.95 p/Share	5,704 Reduced 6.03%	88,895 Ordinary Shares
Feb 27 2025	BUY Grant, award, or other acquisition	-	34,666 Added 26.82%	94,599 Ordinary Shares
Jan 17 2025	SELL Payment of exercise price or tax liability	$404,646 $122.62 p/Share	3,300 Reduced 5.22%	59,933 Ordinary Shares
Jan 17 2025	BUY Grant, award, or other acquisition	-	7,741 Added 10.91%	63,233 Ordinary Shares
Dec 05 2024	SELL Payment of exercise price or tax liability	$9,876 $123.45 p/Share	80 Reduced 0.14%	55,492 Ordinary Shares
Apr 05 2024	SELL Payment of exercise price or tax liability	$200,004 $115.21 p/Share	1,736 Reduced 3.04%	55,357 Ordinary Shares
Mar 05 2024	SELL Payment of exercise price or tax liability	$425,693 $117.53 p/Share	3,622 Reduced 5.97%	57,093 Ordinary Shares
Mar 01 2024	BUY Grant, award, or other acquisition	-	19,916 Added 24.7%	60,715 Ordinary Shares
Jan 17 2024	SELL Payment of exercise price or tax liability	$381,692 $119.13 p/Share	3,204 Reduced 7.28%	40,799 Ordinary Shares
Jan 17 2024	BUY Grant, award, or other acquisition	-	7,079 Added 13.86%	44,003 Ordinary Shares
Nov 10 2023	BUY Grant, award, or other acquisition	-	772 Added 2.05%	36,887 Ordinary Shares
May 18 2023	SELL Open market or private sale	$790,500 $131.75 p/Share	6,000 Reduced 14.29%	35,978 Ordinary Shares
Apr 05 2023	SELL Payment of exercise price or tax liability	$263,424 $145.78 p/Share	1,807 Reduced 4.13%	41,978 Ordinary Shares
Mar 05 2023	SELL Payment of exercise price or tax liability	$222,308 $142.78 p/Share	1,557 Reduced 3.43%	43,785 Ordinary Shares
Mar 03 2023	BUY Grant, award, or other acquisition	-	12,784 Added 21.99%	45,342 Ordinary Shares
Dec 21 2022	SELL Open market or private sale	$421,600 $160.0 p/Share	2,635 Reduced 7.49%	32,558 Ordinary Shares
Apr 05 2022	SELL Payment of exercise price or tax liability	$265,983 $162.88 p/Share	1,633 Reduced 4.46%	34,995 Ordinary Shares
Mar 05 2022	SELL Sale (or disposition) back to the issuer	$110,851 $153.96 p/Share	720 Reduced 1.93%	36,628 Ordinary Shares
Mar 03 2022	BUY Grant, award, or other acquisition	-	11,730 Added 23.9%	37,348 Ordinary Shares
Apr 05 2021	SELL Payment of exercise price or tax liability	$249,536 $164.71 p/Share	1,515 Reduced 5.64%	25,347 Ordinary Shares
Feb 25 2021	BUY Grant, award, or other acquisition	-	10,115 Added 27.35%	26,862 Ordinary Shares

Also insider at

GOSS

Gossamer Bio, Inc. Healthcare

Director

RDG

Renee D Gala

President & COO

San Diego, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells JAZZ shares.

Notify only if

Value

Insider Trading

Get notified when an Jazz Pharmaceuticals PLC insider buys or sells JAZZ shares.

Notify only if

Operation

Value

Type

News

Receive news related to Jazz Pharmaceuticals plc

Track Activities on JAZZ

Account